Internal Medicine, Interventional Cardiology · Lexington, KY
NPI
1740255314
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
161 N Eagle Creek Dr, Suite 400
Lexington, KY, 40509
Phone (859) 226-0031
Groups this clinician bills Medicare through
Medicare paid, 2024
$326K
3,768 services
Medicare patients, 2024
745
Average age 74
Drug cost, 2024
$5.3M
11,884 prescriptions
Company payments, 2025
$85K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Avichai Eres was code 99214 (office e&m - established), 793 times for 365 patients. In total Avichai Eres billed 3,768 services in 78 codes, and Medicare paid $326K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 793 | 365 | $84.41 | $67K |
| 99213 Office E&M - Established | Office | 460 | 300 | $59.17 | $27K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 328 | 82 | $5.85 | $1,920 |
| 93356 Echocardiography (TTE/TEE) | Office | 232 | 229 | $25.55 | $5,927 |
| 93306 Echocardiography (TTE/TEE) | Office | 231 | 229 | $124.23 | $29K |
| 93296 External Electrocardiographic Monitoring | Office | 126 | 53 | $13.46 | $1,696 |
| 99454 E&M - Miscellaneous | Office | 92 | 19 | $30.62 | $2,817 |
| 93294 External Electrocardiographic Monitoring | Office | 90 | 36 | $19.77 | $1,779 |
| 93015 Electrocardiogram | Office | 87 | 87 | $44.13 | $3,840 |
| 93970 Duplex Scan - Extremity Veins | Office | 81 | 74 | $122.92 | $9,956 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 80 | 40 | $23.02 | $1,841 |
| 78452 Myocardial Perfusion Scan | Office | 66 | 66 | $287.58 | $19K |
| 93880 Duplex Scan - Extracranial Arteries | Office | 63 | 63 | $111.26 | $7,009 |
| 93306 Echocardiography (TTE/TEE) | Facility | 59 | 57 | $50.76 | $2,995 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 56 | 42 | $30.18 | $1,690 |
By year: 2022 $661K for 6,301 services; 2023 $566K for 4,818 services; 2024 $326K for 3,768 services.
Medicare prescription drug claims, 2024
In 2024, the drug Avichai Eres prescribed most often to Medicare patients was Xarelto (Rivaroxaban), with 968 prescriptions and refills. In total Avichai Eres wrote 11,884 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xarelto Rivaroxaban | 968 | 2,173 | 254 | $1.2M |
| Rosuvastatin Calcium Generic | 755 | 2,046 | 244 | $10K |
| Atorvastatin Calcium Generic | 705 | 1,880 | 232 | $5,814 |
| Carvedilol Generic | 597 | 1,561 | 189 | $4,036 |
| Metoprolol Succinate Generic | 551 | 1,493 | 185 | $6,338 |
| Ozempic Semaglutide | 534 | 785 | 128 | $674K |
| Valsartan-Hydrochlorothiazide Valsartan/Hydrochlorothiazide | 474 | 1,189 | 156 | $12K |
| Jardiance Empagliflozin | 458 | 986 | 139 | $552K |
| Entresto Sacubitril/Valsartan | 382 | 806 | 110 | $519K |
| Valsartan Generic | 325 | 841 | 115 | $5,724 |
| Amlodipine Besylate Generic | 314 | 872 | 109 | $1,473 |
| Clopidogrel Clopidogrel Bisulfate | 313 | 813 | 102 | $2,565 |
| Ezetimibe Generic | 297 | 821 | 99 | $5,265 |
| Spironolactone Generic | 271 | 719 | 100 | $2,397 |
| Repatha Sureclick Evolocumab | 262 | 475 | 65 | $268K |
Brand drugs: - claims; generic drugs: 7,566 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Avichai Eres $85K ($85K in general payments such as food, travel and fees) from 22 companies. The largest payer was Novo Nordisk Inc with $49K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 30 | $49K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 32 | $28K |
| Lilly USA, LLC LLY | 5 | $3,960 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $2,725 |
| Pfizer Inc. PFE | 16 | $250 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $238 |
| AtriCure, Inc. ATRC | 5 | $205 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $187 |
| Merck Sharp & Dohme LLC MRK | 9 | $151 |
| Abiomed JNJ | 14 | $138 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.